Faecalibacterium
Faecalibacterium: A Gut Microbiome Powerhouse
Faecalibacterium, a genus of bacteria residing in the human gut microbiome, plays a crucial role in maintaining overall health and well-being. Its prevalence and impact on human health have made it a subject of intense research, revealing its therapeutic potential and association with various diseases.
Description
Faecalibacterium is an anaerobic, gram-negative bacteria belonging to the Ruminococcaceae family. It is a prominent member of the gut microbiome, typically accounting for 1-5% of the total bacterial population. Faecalibacterium species are characterized by their ability to produce butyrate, a short-chain fatty acid that provides energy for colonocytes and has anti-inflammatory properties.
Associated Diseases
Recent studies have linked Faecalibacterium to a range of diseases and conditions, including:
- Inflammatory Bowel Disease (IBD): Reduced levels of Faecalibacterium have been observed in individuals with Crohn‘s disease and ulcerative colitis, indicating its role in maintaining intestinal homeostasis.
- Obesity and Type 2 Diabetes: Low Faecalibacterium abundance has been associated with increased risk of obesity and type 2 diabetes, suggesting its involvement in metabolic regulation.
- Colorectal Cancer: Certain Faecalibacterium strains have been shown to suppress the growth of colorectal cancer cells, highlighting their potential as a probiotic.
Did you Know ?
A significant finding from recent research revealed that individuals with high levels of Faecalibacterium in their gut microbiome were 30% less likely to develop recurrent Clostridioides difficile infection (CDI), a serious form of diarrhea. This finding underscores the protective effects of Faecalibacterium against harmful pathogens.
